Opsonized erythrocyte ghosts for liver-targeted delivery of antisense oligodeoxynucleotides

Biomaterials

Volumn 30, Issue 5, 2009, Pages 959-967

  Kim, Sang Hee ^a   Kim, Eun Joong ^b   Hou, Joon Hyuk ^a   Kim, Jung Mogg ^c   Choi, Han Gon ^d   Shim, Chang Koo ^b   Oh, Yu Kyoung ^a  

^a Korea University   (South Korea)

^b Seoul National University   (South Korea)

^c Hanyang University   (South Korea)

^d Yeungnam University   (South Korea)

Author keywords

Antisense delivery; Antisense quantification; Erythrocyte ghost; Liver targeting; Opsonization

Indexed keywords

ANTISENSE DELIVERY; ANTISENSE OLIGODEOXYNUCLEOTIDES; ANTISENSE QUANTIFICATION; BIODISTRIBUTION; BIOTINYLATED; COMPLEX FORMATIONS; DELIVERY METHODS; DELIVERY SYSTEMS; DINITROPHENOL; ENCAPSULATION EFFICIENCIES; ERYTHROCYTE GHOST; ERYTHROCYTE GHOSTS; FEMTOMOLE LEVELS; IMMUNOSORBENT ASSAYS; IN-VIVO; MEAN RESIDENCE TIMES; OPSONIZATION; POLYETHYLENEIMINE; STREPTAVIDIN; TARGETED DELIVERIES; THERAPEUTIC APPLICATIONS;

CIVIL AVIATION; DRUG PRODUCTS; PHENOLS;

LIVER;

2,4 DINITROPHENOL; ANTISENSE OLIGODEOXYNUCLEOTIDE; POLYETHYLENEIMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOTINYLATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; ENCAPSULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE GHOST; FEMALE; LIVER; MEAN RESIDENCE TIME; MOUSE; NONHUMAN; OPSONIZATION; PRIORITY JOURNAL;

ANIMALS; CELL LINE; DRUG DELIVERY SYSTEMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE MEMBRANE; FEMALE; LIVER; MICE; MICE, INBRED BALB C; OLIGONUCLEOTIDES, ANTISENSE; POLYETHYLENEIMINE; POLYMERASE CHAIN REACTION;

EID: 57549118342     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2008.10.031     Document Type: Article

References (24)

1. Tamm I., and Wagner M. Antisense therapy in clinical oncology: preclinical and clinical experiences. Mol Biotechnol 33 (2006) 221-238
2. Andrei G., De Clercq E., and Snoeck R. Novel inhibitors of human CMV. Curr Opin Investig Drugs 9 (2008) 132-145
3. Remaut K., Lucas B., Raemdonck K., Braeckmans K., Demeester J., and De Smedt S.C. Protection of oligonucleotides against enzymatic degradation by pegylated and nonpegylated branched polyethyleneimine. Biomacromolecules 8 (2007) 1333-1340
4. Kawakami S., Higuchi Y., and Hashida M. Nonviral approaches for targeted delivery of plasmid DNA and oligonucleotide. J Pharm Sci 97 2 (2008) 726-745
5. Byun H.M., Suh D., Yoon H., Kim J.M., Choi H.G., Kim W.K., et al. Erythrocyte ghost-mediated gene delivery for prolonged and blood-targeted expression. Gene Ther 11 (2004) 492-496
6. Efler S.M., Zhang L., Noll B.O., Uhlmann E., and Davis H.L. Quantification of oligodeoxynucleotides in human plasma with a novel hybridization assay offers greatly enhanced sensitivity over capillary gel electrophoresis. Oligonucleotides 15 (2005) 119-131
7. Zhang G., Lin J., Srinivasan K., Kavetskaia O., and Duncan J.N. Strategies for bioanalysis of an oligonucleotide class macromolecule from rat plasma using liquid chromatography-tandem mass spectrometry. Anal Chem 79 (2007) 3416-3424
8. Zeng D., Wang J., Yin L., Zhang Y., Zhang Y., and Zhou F. Sequence-specific analysis of oligodeoxynucleotides by precipitate-amplified surface plasmon resonance measurements. Front Biosci 12 (2007) 5117-5123
9. Powers J.D. Statistical considerations in pharmacokinetic study design. Clin Pharmacokinet 24 (1993) 38087
10. Millán C.G., Marinero M.L., Castañeda A.Z., and Lanao J.M. Drug, enzyme and peptide delivery using erythrocytes as carriers. J Control Release 95 (2004) 27-49
11. Rossi L., Serafini S., Pierigé F., Antonelli A., Cerasi A., Fraternale A., et al. Erythrocyte-based drug delivery. Expert Opin Drug Deliv 2 (2005) 311-322
12. Pierigè F., Serafini S., Rossi L., and Magnani M. Cell-based drug delivery. Adv Drug Deliv Rev 60 (2008) 286-295
13. Chiarantini L., Cerasi A., Fraternale A., Andreoni F., Scarí S., Giovine M., et al. Inhibition of macrophage iNOS by selective targeting of antisense PNA. Biochemistry 41 (2002) 8471-8477
14. Millán C.G., Castañeda A.Z., Marinero M.L., and Lanao J.M. Factors associated with the performance of carrier erythrocytes obtained by hypotonic dialysis. Blood Cells Mol Dis 33 (2004) 132-140
15. Wilchek M., Bayer E.A., and Livnah O. Essentials of biorecognition: the (strept)avidin-biotin system as a model for protein-protein and protein-ligand interaction. Immunol Lett 103 (2006) 27-32
16. Wei X., Dai G., Marcucci G., Liu Z., Hoyt D., Blum W., et al. A specific picomolar hybridization-based ELISA assay for the determination of phosphorothioate oligonucleotides in plasma and cellular matrices. Pharm Res 23 (2006) 1251-1264
17. 68Ga-labelled phosphodiester, phosphorothioate, and 2′-O-methyl phosphodiester oligonucleotides in normal rats. Eur J Pharm Sci 26 (2005) 26-38
18. Gomes dos Santos A.L., Bochot A., Tsapis N., Artzner F., Bejjani R.A., Thillaye-Goldenberg B., et al. Oligonucleotide-polyethylenimine complexes targeting retinal cells: structural analysis and application to anti-TGF beta-2 therapy. Pharm Res 23 (2006) 770-781
19. Akinc A., Thomas M., Klibanov A.M., and Langer R. Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. J Gene Med 7 (2005) 657-663
20. Oh Y.K., and Swanson J.A. Different fates of phagocytosed particles after delivery into macrophage lysosomes. J Cell Biol 132 (1996) 585-593
21. Qi X.R., Yan W.W., and Shi J. Hepatocytes targeting of cationic liposomes modified with soybean sterylglucoside and polyethylene glycol. World J Gastroenterol 11 (2005) 4947-4952
22. Zhu L., Ye Z., Cheng K., Miller D.D., and Mahato R.I. Site-specific delivery of oligonucleotides to hepatocytes after systemic administration. Bioconjug Chem 19 (2008) 290-298
23. Okazawa H., Motegi S., Ohyama N., Ohnishi H., Tomizawa T., Kaneko Y., et al. Negative regulation of phagocytosis in macrophages by the CD47-SHPS-1 system. J Immunol 174 (2005) 2004-2011
24. Huang Z.Y., Barreda D.R., Worth R.G., Indik Z.K., Kim M.K., Chien P., et al. Differential kinase requirements in human and mouse Fc-gamma receptor phagocytosis and endocytosis. J Leukoc Biol 80 (2006) 1553-1562